Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > Proxy Advisors

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Feb 26, 2024 10:16am

40 Views

Post# 35898924

RE:Proxy Advisors

"I love the dropping of the oat chewy thing in the NR."

It was recently approved by Heath Canada. You've moaned about the beta glucan pill clinical trial. This may be the result.

Approved claims for CZO's Chewy bar:

Recommended use or purpose:: Helps improve (postprandial) glucose metabolism (within two hours after a meal). Helps reduce/lower (LDL) cholesterol (which is one risk factor for the development of coronary heart disease). Helps support and maintain a healthy digestive system. Provides support for healthy (postprandial) glucose metabolism (within two hours after a meal). Source of fiber for the maintenance of good health.

---------

With CZO's successful scaling of the avenanthramide malted technology for food applications and the signing of a major company to try it out adding avenanthramide to the chewy bar may further be interesting and provide complementary heart health, and diabetes management claims. It could address heart health with cholesterol and inflammation reduction. It could be a unique product with both of CZO's bioactives. CZO's avenanthramide pill clinical trial could strengthen claims. It could also be an exercise bar with avenanthramide given the ability to address exercise inflammation.

<< Previous

Bullboard Posts

Next >>

Two Venture-listed mining stocks file NI 43-101 reports